An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Ulcerative Colitis: the LOVE-UC Study (LOw Countries VEdolizumab in UC Study)
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms LOVE-UC
- 04 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 04 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated